Steroid treatment for severe stroke with low lymphocyte count
Treatments studied
Part of Brain & nervous system, Immune system & allergy clinical trials.
This trial tests if the steroid methylprednisolone helps people who have had a major stroke and also have low infection-fighting white blood cells (lymphocytes). It is for patients who are getting a procedure to remove the clot (thrombectomy) within 24 hours of the stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had a large stroke on one side of the brain, confirmed by a brain scan.
- Your stroke started within the last 24 hours.
- You are scheduled to have a clot-removal procedure (thrombectomy).
- A blood test shows your lymphocyte count is low (below 0.8).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a specialized clot-removal treatment for people who had a mild but disabling stroke up to 24 hours ago and have a large artery blockage in the brain. The goal is to see if this precision therapy can help reduce disability and improve recovery.
This trial tests a stroke treatment plan for adults after they have a clot removed by a catheter procedure (endovascular treatment). It focuses on people with certain artery blockages and specific scan results, aiming to improve recovery after successful clot removal.
This study tests if adding a steroid medication (methylprednisolone) to the standard procedure of removing a large blood clot from the brain can improve recovery for people with a severe ischemic stroke. It is for adults who can have the clot removal procedure and have a large area of brain damage.
This trial tests if giving a steroid (methylprednisolone) directly into the brain artery after successful clot removal improves recovery. It is for people who had a large stroke in the front part of the brain and got the clot out within 24 hours.
This trial tests whether injecting a steroid (methylprednisolone) directly into brain blood vessels after removing a stroke clot helps reduce brain swelling and improve recovery. You would be eligible if you had a large clot stroke in the front part of your brain that was successfully removed within the past 24 hours.
This study tests if adding the steroid methylprednisolone to the standard clot-removal procedure (thrombectomy) can improve recovery for people with a large ischemic stroke, compared to thrombectomy alone.
Hear when a new Large Infarct Core trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.